+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Platelet Aggregation Devices Market - Global Forecast 2025-2030- Product Image
Platelet Aggregation Devices Market - Global Forecast 2025-2030- Product Image
Sale

Platelet Aggregation Devices Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968880
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Platelet Aggregation Devices Market grew from USD 605.63 million in 2024 to USD 714.97 million in 2025. It is expected to continue growing at a CAGR of 17.22%, reaching USD 1.57 billion by 2030.

Unveiling the Transformative Significance of Platelet Aggregation Devices in Enhancing Clinical Hemostasis Diagnostics and Therapeutic Monitoring Approaches

Platelet aggregation devices have emerged as indispensable tools in the realm of hemostasis monitoring, offering clinicians a window into the complex dynamics of blood clot formation and patient response to antiplatelet therapies. As cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, the precision and reliability of these instruments are paramount. Through innovative assay designs and refined detection technologies, modern platelet aggregation systems enable the quantification of platelet function under physiologically relevant conditions, thereby guiding therapeutic decisions and informing personalized care pathways.

Moreover, the integration of digital data capture and advanced analytics has transformed these platforms from standalone laboratory instruments into central components of comprehensive diagnostic workflows. By bridging the gap between traditional bench testing and real-time clinical insights, today’s aggregation devices drive efficiencies in both research and clinical settings. Consequently, the market landscape is witnessing intensified investment in device innovation, with stakeholders seeking robust solutions that support high throughput, reproducibility, and seamless interoperability with laboratory information systems.

Charting the Evolution of Platelet Aggregation Technology Through Innovations, Digital Integration, and Personalized Medicine Paradigms

The landscape of platelet aggregation technology is undergoing a profound transformation driven by breakthroughs in microfluidics, artificial intelligence, and point-of-care connectivity. Rather than relying solely on traditional optical measurements, next-generation systems leverage miniaturized channels and sensor arrays to simulate vascular shear stress, yielding more clinically relevant data. At the same time, machine learning algorithms are being embedded to detect subtle patterns in aggregation curves, reducing manual interpretation errors and enhancing predictive accuracy.

Furthermore, the shift toward personalized medicine has spurred demand for assays that can integrate patient genetic profiles and biomarker signatures with functional platelet responses. This convergence of molecular diagnostics and aggregometry is fostering hybrid platforms capable of delivering both phenotypic and genotypic insights in a single workflow. Consequently, collaborations between device manufacturers, software developers, and academic research centers are deepening, as stakeholders recognize the value of multidisciplinary innovation to address evolving clinical needs.

Evaluating the Multifaceted Impact of 2025 United States Tariff Policies on Supply Chains, Costs, and Strategic Sourcing in Platelet Aggregation Market

In 2025, the implementation of updated United States tariff measures is poised to create ripple effects across the platelet aggregation device supply chain. Components such as precision optics, microfluidic substrates, and single-use assay cartridges-often sourced from international suppliers-are expected to incur elevated import duties. As a result, manufacturers may face increased cost pressures that could influence pricing structures and procurement strategies.

To mitigate these challenges, industry players are exploring diversified sourcing frameworks, including nearshoring select production processes and forging strategic alliances with domestic component producers. At the same time, some organizations are accelerating investment in local manufacturing capabilities to reduce dependency on subject to tariffs. Ultimately, navigating the cumulative impact of these policy shifts will require a balanced approach that anticipates both short-term cost fluctuations and long-term supply chain resilience.

Deciphering Comprehensive Market Segmentation to Illuminate Product, Testing Modalities, and End-User Dynamics in Platelet Aggregation

A nuanced understanding of market segmentation is essential for uncovering growth vectors in the platelet aggregation domain. By examining product type, the market can be distinguished between benchtop instruments, which offer extensive customization and integration into centralized laboratories, and portable instruments that enable rapid point-of-care assessments in decentralized settings. When viewed through the lens of test type, the market further divides into flow cytometry methods segmented into direct flow cytometry and functional flow cytometry, impedance aggregometry techniques separated into platelet rich plasma impedance and whole blood impedance, and light transmission aggregometry approaches differentiated by optical density assays and turbidimetric assays.

In addition, a modality-based perspective reveals two primary categories: in vitro assays encompassing aggregometry systems and impedance systems, and point of care systems including cartridge-based platforms and handheld devices. Finally, end user segmentation highlights the diverse landscape of academic institutions split between teaching hospitals and universities, diagnostic laboratories differentiated as central laboratories and point-of-care laboratories, hospitals comprising both community hospitals and tertiary hospitals, and research institutes consisting of biotechnology firms and pharmaceutical companies. Together, these segmentation frameworks illuminate distinct user requirements, technological preferences, and growth opportunities across the value chain.

Unraveling Regional Dynamics Across Americas, Europe Middle East Africa, and Asia Pacific to Guide Strategic Expansion in Hemostasis Diagnostics

Regional dynamics play a crucial role in shaping the adoption and innovation of platelet aggregation devices. In the Americas, advanced healthcare infrastructure and well-established reimbursement mechanisms have fostered an environment conducive to rapid clinical adoption and ongoing R&D investment. Laboratories in North America are leading early validation studies, while Latin American regions, buoyed by targeted government initiatives, are gradually expanding access to advanced hemostasis testing.

Meanwhile, the Europe, Middle East & Africa region benefits from harmonized regulatory frameworks and a robust network of academic and clinical research centers. Western European markets exhibit high demand for standardized, high-throughput platforms, whereas emerging markets across the Middle East and Africa are demonstrating growing interest in cost-effective, portable solutions that address healthcare accessibility challenges. Similarly, in Asia-Pacific, expanding healthcare expenditure, rising prevalence of cardiovascular disorders, and collaborations between global manufacturers and local stakeholders are driving significant momentum. Countries across East Asia and Southeast Asia are investing heavily in domestic manufacturing capabilities, which further accelerates market penetration and innovation.

Spotlighting Leading Innovators and Collaborators Shaping the Competitive Platelet Aggregation Device Ecosystem and Driving Market Differentiation

Leading companies in the platelet aggregation device ecosystem are differentiating themselves through strategic innovation, partnerships, and geographic diversification. Industry veterans have prioritized the development of integrated software suites that enable seamless data analysis and cloud connectivity, while emerging players are focusing on specialized assay chemistries that enhance sensitivity and reduce assay time. Meanwhile, strategic alliances with academic institutions and contract research organizations are facilitating co-development of application-specific workflows for antiplatelet drug trials.

In addition, mergers and acquisitions have become a prominent trend, with larger firms acquiring niche technology providers to broaden their product portfolios and strengthen service capabilities. Collaborative agreements with regional distributors and healthcare networks are supporting deeper market penetration, particularly in underserved areas. Collectively, these strategic initiatives underline a competitive landscape that is both collaborative and dynamic, driving continuous improvement in device performance, reliability, and value proposition.

Implementing Strategic Roadmaps for R&D, Regulatory Engagement, and Collaborative Partnerships to Elevate Platelet Aggregation Device Innovation

To capitalize on emerging opportunities and navigate the evolving regulatory and tariff environment, industry leaders should adopt a multi-pronged strategy that emphasizes agility and foresight. First, investing in R&D initiatives aimed at miniaturizing assay platforms and integrating artificial intelligence-driven analytics will yield higher throughput and more actionable insights. By prioritizing user-centric design and workflow automation, developers can accelerate adoption in both clinical and research settings.

Furthermore, proactive engagement with regulatory authorities will expedite approval processes and ensure alignment with emerging quality standards. Building collaborative partnerships with key opinion leaders and academic centers can also validate new technologies and strengthen clinical credibility. Additionally, diversifying supply chains and establishing nearshore manufacturing capabilities will mitigate tariff-related risks and enhance resilience. Finally, expanding outreach into emerging regional markets through targeted education programs and local distributor networks will unlock new revenue streams and foster long-term loyalty among end users.

Outlining Rigorous Quantitative and Qualitative Research Frameworks to Validate Insights and Ensure Analytical Rigor in Market Assessment

Our research methodology combines rigorous primary and secondary approaches to deliver a robust and credible analysis. Primary research includes detailed interviews with thought leaders, clinicians, and procurement specialists across major markets, complemented by structured surveys designed to capture real-world user experiences and unmet needs. In tandem, secondary research encompasses comprehensive reviews of peer-reviewed literature, regulatory documents, clinical trial registries, and industry white papers.

Quantitative analysis is grounded in statistical modeling and scenario analysis to identify key drivers, adoption patterns, and potential risks. Triangulation of data from multiple sources enhances the validity of findings, while iterative validation sessions with experts ensure alignment with current market realities. The methodology further incorporates geographic segmentation and detailed assessment of technological sub-segments, providing a holistic view of the competitive landscape and emerging trends.

Concluding Strategic Perspectives on Platelet Aggregation Device Evolution, Market Resilience, and Future Pathways for Clinical Application Impact

In conclusion, platelet aggregation devices stand at the forefront of modern hemostasis diagnostics, with continuous innovations reshaping how clinicians assess and monitor platelet function. The convergence of advanced detection technologies, data analytics, and personalized medicine is creating fertile ground for next-generation platforms capable of delivering comprehensive and rapid insights. While emerging tariff policies and shifting supply chain dynamics present challenges, they also drive strategic reinvention and localized manufacturing initiatives.

By adopting a nuanced segmentation approach and responding to regional market nuances, stakeholders can uncover targeted growth opportunities and refine product offerings. Companies that balance technological innovation with regulatory foresight and supply chain resilience will be best positioned to capitalize on the evolving diagnostic landscape. Ultimately, the insights presented in this executive summary underscore a market in flux, characterized by collaboration, competition, and a shared commitment to advancing patient care and scientific discovery.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Benchtop Instruments
    • Portable Instruments
  • Test Type
    • Flow Cytometry
      • Direct Flow Cytometry
      • Functional Flow Cytometry
    • Impedance Aggregometry
      • Platelet Rich Plasma Impedance
      • Whole Blood Impedance
    • Light Transmission Aggregometry
      • Optical Density Assays
      • Turbidimetric Assays
  • Modality
    • In Vitro Assays
      • Aggregometry Systems
      • Impedance Systems
    • Point Of Care Systems
      • Cartridge-Based Systems
      • Handheld Devices
  • End User
    • Academic Institutions
      • Teaching Hospitals
      • Universities
    • Diagnostic Laboratories
      • Central Laboratories
      • Point-Of-Care Laboratories
    • Hospitals
      • Community Hospitals
      • Tertiary Hospitals
    • Research Institutes
      • Biotechnology Firms
      • Pharmaceutical Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Werfen Life Science SLU
  • Diagnostica Stago SAS
  • DiaMed AG
  • Helena Laboratories Corporation
  • Sienco Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Haemonetics Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of portable microfluidic platelet aggregometers for point-of-care cardiac risk assessment
5.2. Integration of AI-driven image analysis algorithms in platelet aggregation assays for rapid diagnostics
5.3. Development of single-use disposable cartridges enabling decentralized platelet function testing in outpatient settings
5.4. Rise of viscoelastic testing platforms to complement traditional light transmission platelet aggregation devices in surgical monitoring
5.5. Adoption of cloud-based data management systems to streamline multi-site platelet aggregation study workflows
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Platelet Aggregation Devices Market, by Product Type
8.1. Introduction
8.2. Benchtop Instruments
8.3. Portable Instruments
9. Platelet Aggregation Devices Market, by Test Type
9.1. Introduction
9.2. Flow Cytometry
9.2.1. Direct Flow Cytometry
9.2.2. Functional Flow Cytometry
9.3. Impedance Aggregometry
9.3.1. Platelet Rich Plasma Impedance
9.3.2. Whole Blood Impedance
9.4. Light Transmission Aggregometry
9.4.1. Optical Density Assays
9.4.2. Turbidimetric Assays
10. Platelet Aggregation Devices Market, by Modality
10.1. Introduction
10.2. In Vitro Assays
10.2.1. Aggregometry Systems
10.2.2. Impedance Systems
10.3. Point Of Care Systems
10.3.1. Cartridge-Based Systems
10.3.2. Handheld Devices
11. Platelet Aggregation Devices Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.2.1. Teaching Hospitals
11.2.2. Universities
11.3. Diagnostic Laboratories
11.3.1. Central Laboratories
11.3.2. Point-Of-Care Laboratories
11.4. Hospitals
11.4.1. Community Hospitals
11.4.2. Tertiary Hospitals
11.5. Research Institutes
11.5.1. Biotechnology Firms
11.5.2. Pharmaceutical Companies
12. Americas Platelet Aggregation Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Platelet Aggregation Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Platelet Aggregation Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Siemens Healthineers AG
15.3.2. Sysmex Corporation
15.3.3. Werfen Life Science SLU
15.3.4. Diagnostica Stago SAS
15.3.5. DiaMed AG
15.3.6. Helena Laboratories Corporation
15.3.7. Sienco Inc.
15.3.8. Bio/Data Corporation
15.3.9. F. Hoffmann-La Roche AG
15.3.10. Haemonetics Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PLATELET AGGREGATION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PLATELET AGGREGATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PLATELET AGGREGATION DEVICES MARKET: RESEARCHAI
FIGURE 24. PLATELET AGGREGATION DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. PLATELET AGGREGATION DEVICES MARKET: RESEARCHCONTACTS
FIGURE 26. PLATELET AGGREGATION DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 154. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 155. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 156. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 157. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 158. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 159. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 160. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 161. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 162. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 163. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 164. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 165. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 168. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 169. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 170. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 171. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 184. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

  • Siemens Healthineers AG
  • Sysmex Corporation
  • Werfen Life Science SLU
  • Diagnostica Stago SAS
  • DiaMed AG
  • Helena Laboratories Corporation
  • Sienco Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Haemonetics Corporation

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 714.97 Million
Forecasted Market Value ( USD ) by 2030 $ 1570 Million
Compound Annual Growth Rate17.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Platelet Aggregation Devices: Market Share, and Growth Analysis by Product Type (Manual Platelet Aggregation Devices, Automated Platelet Aggregation Devices), Application, End User, Technology - Product Image

Platelet Aggregation Devices: Market Share, and Growth Analysis by Product Type (Manual Platelet Aggregation Devices, Automated Platelet Aggregation Devices), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Platelet Aggregation Device Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Platelet Aggregation Device Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Platelet Aggregation Function Analyzer Market - Global Forecast 2025-2030 - Product Image

Platelet Aggregation Function Analyzer Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Platelet Aggregation Devices Market Report 2025 - Product Image

Platelet Aggregation Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Platelet Aggregation Devices - Global Strategic Business Report - Product Image

Platelet Aggregation Devices - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From

About the Platelet Aggregation Market

The Platelet Aggregation market is a segment of the Medical Devices industry that focuses on the diagnosis and treatment of cardiovascular diseases. Platelet Aggregation is a process in which platelets in the blood clump together to form a clot. Platelet Aggregation tests are used to diagnose and monitor conditions such as coronary artery disease, stroke, and deep vein thrombosis. Platelet Aggregation devices are used to measure the speed and strength of platelet aggregation in the blood. These devices are used in hospitals, clinics, and laboratories. The Platelet Aggregation market is driven by the increasing prevalence of cardiovascular diseases, technological advancements in platelet aggregation devices, and the growing demand for point-of-care testing. The market is expected to witness a steady growth in the coming years. Some of the major players in the Platelet Aggregation market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Helena Laboratories, and Bio/Data Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.